Latest News | JB Pharma Q4 PAT Rises 3.5 Pc to Rs 88 Crore

New Delhi, May 24 (PTI) JB Pharma on Wednesday said its profit after tax rose by 3.5 per cent to Rs 88 crore for the fourth quarter ended March 31, 2023.

The company had reported a profit after tax (PAT) at Rs 85 crore in the January-March quarter of 2021-22 fiscal.

Also Read | New Parliament Building Inauguration: Parliament Not PM Narendra Modi's Own House To Inaugurate, Will Boycott Ceremony, Says TMC MP Mahua Moitra.

Revenue of the company stood at Rs 762 crore in the fourth quarter of FY23 as against Rs 625 crore in the same period of FY22, JB Pharma said in a statement.

For the last fiscal, the company reported revenue of Rs 3,149 crore as compared with Rs 2,424 crore in FY22.

Also Read | Job Market Experienced Salary Growth Dip in FY2023 to 9% Led by Agri, Agro Chem, Auto, BFSI Sectors, Says Report.

During the same period, PAT stood at Rs 410 crore as against Rs 386 crore, recording a growth of 6 per cent, JB Pharma said.

The drug maker continued its growth journey in the fourth quarter, thereby ending FY23 with a strong performance across business segments, JB Pharma CEO Nikhil Chopra said.

"While we are cautious of the inflationary environment our efforts are aimed at executing well, with productivity and cost optimisation as drivers, in order to deliver improved operating margins," he added.

Shares of the company ended 1.59 per cent down at Rs 1,919.40 apiece on the BSE.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)